Centre says over two billion COVID-19 vaccine doses to be available between August and December 2021 Dr V K Paul, member (health), NITI Aayog said that by the first quarter of the next year, the number is likely to be three billion
Restricted emergency use approval from DCGI for Zydus’ PegIFN ‘Virafin’ to treat moderate… Single dose of Virafin administered subcutaneously early on shows significant clinical and virological improvement in moderate…
Zydus Cadila awaits nod for ZyCoV-D phase 3 trial Submits Phase I/II clinical trial data of ZyCoV-D, which reportedly shows immunogenicity in Phase II in healthy subjects as also…
3 Indian vaccines in phase-2 has created Apollo 11 moment for India: Dr V K Paul No pressure on regulators for approval of the vaccine, final call on allowing emergency use approval will be made on scientific…
Making the right COVID choices in 2021 Having a choice of COVID-19 vaccines is just the first step. Besides the logistics and pharmacovigilance to track AEFIs, the other…
Trial of COVAXIN and ZyCov-D marks ‘beginning of the end’, says scientist in article The article which has been published on the Vigyan Prasar portal said it could take anywhere between 15 to 18 months before a…